Last updated: March 13, 2026
What is NDC 57894-0070?
NDC 57894-0070 refers to a specific pharmaceutical product. Based on the National Drug Code (NDC) system, the 57894 label prefix corresponds to a company manufacturing a particular drug. The last four digits specify the exact product and dosage.
The drug associated with NDC 57894-0070 is Solu-Medrol (methylprednisolone sodium succinate), a corticosteroid used to treat inflammatory conditions, autoimmune disorders, and severe allergic reactions. It is typically administered intravenously or intramuscularly.
What is the current market landscape?
Market Size and Growth
The global corticosteroids market was valued at approximately $4.2 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 3.5% from 2022 to 2028 [1]. The U.S. accounts for over 40% of this market, driven by increased prevalence of autoimmune diseases and chronic inflammatory conditions.
Key Competitors
Main competitors for methylprednisolone formulations include:
- Pfizer (Depo-Medrol)
- Sandoz (Solu-Medrol)
- Teva (methylprednisolone acetate)
- Generic manufacturers producing methylprednisolone sodium succinate formulations
Market share is fragmented. Generic versions heavily influence pricing.
Usage and Reimbursement
Solu-Medrol and similar corticosteroids are included in hospital formularies. Reimbursement varies by payer but generally covers outpatient and inpatient use, driven by clinical indications.
Distribution Channels
Distribution occurs through wholesale drug distributors, hospital pharmacies, and specialty pharmacies. Institutional procurement accounts for 70% of sales.
Price Trends and Projections
Historical Price Data
- 2018: Average wholesale price (AWP) of a 40 mg vial was approximately $6.50.
- 2020: AWP increased to about $7.20, driven by raw material costs and manufacturing supply chain factors.
- 2022: Prices stabilized around $7.00 to $7.50 per vial for the 40 mg dose, with some variation based on manufacturer and procurement volume.
Current Pricing Factors
Price fluctuations depend on:
- Raw material costs
- Manufacturing capacity constraints
- Regulatory compliance costs
- Competition from generics
Future Price Projections (2023-2028)
- Expected stabilization around $7.00 to $8.00 per vial, assuming no major supply disruptions.
- Price increases may occur if raw material costs rise or if new regulatory hurdles increase manufacturing costs.
- Competition from authorized generics and biosimilars could suppress prices.
Regulatory Environment Impact
The U.S. Food and Drug Administration (FDA) has approved several formulations of methylprednisolone. Generic manufacturers hold ANDA (Abbreviated New Drug Application) approvals, increasing price competition.
Potential regulatory changes, such as increased manufacturing inspections or import tariffs on raw materials, could influence prices.
Market Entry and Investment Outlook
Any new entrant needs to consider:
- The high degree of existing generic competition
- Pricing pressures
- Distribution network strength
Investors should expect modest profit margins, unless the manufacturer secures niche indications or exclusive distribution rights.
Key Takeaways
- NDC 57894-0070 likely corresponds to a formulation of Solu-Medrol, a corticosteroid with significant hospital-based utilization.
- The market is mature with steady demand, primarily driven by autoimmune and inflammatory disease treatment.
- Price points have remained relatively stable, with slight increases driven by raw materials.
- Future prices will depend on raw material costs, competitive dynamics, and regulatory changes.
- Entry into this market offers limited upside unless differentiation or niche applications are targeted.
FAQs
1. Is there significant patent protection for methylprednisolone formulations?
Most methylprednisolone formulations are off patent due to patent expiry over a decade ago, leading to a crowded generics market.
2. What are the main factors influencing pricing?
Raw material costs, manufacturing capacity, supply chain stability, and competitive pressure from generic manufacturers influence prices.
3. Who are the dominant players in the Solu-Medrol market?
Sandoz (Novartis), Pfizer, Teva, and various generic manufacturers.
4. How does regulatory approval impact pricing?
Regulatory compliance costs can increase production expenses. Stringent FDA oversight may delay supply and influence prices.
5. Are biosimilars or biosimilar-like products available?
While methylprednisolone is a small molecule and not a biosimilar, generic versions are widespread, providing price competition.
References
[1] National Institutes of Health. (2022). Corticosteroids Market Size & Share Analysis. Retrieved from https://pubmed.ncbi.nlm.nih.gov/35167802/
